Halverson, Sandra L. External Entity


Sort by

Selected publications

  • No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.  Gynecologic Oncology. 2016 Information Resource GET IT
    Times cited: 2
  • Prediction of breast cancer risk based on profiling with common genetic variants.  Journal of the National Cancer Institute2015 Academic Article GET IT
    Times cited: 66